Linkage of malignant hyperthermia and hyperkalemic periodic paralysis to the adult skeletal muscle sodium channel (SCN4A) gene in a large pedigree

American Journal of Medical Genetics

Volumn 76, Issue 1, 1998, Pages 21-27

  Moslehi, Roxana ^a   Langlois, Sylvie ^a   Yam, Irene ^a   Friedman, J M ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BC CHILDREN S HOSPITAL   (Canada)

Author keywords

Adult skeletal muscle sodium channel gene SCN4A; Hyperkalemic periodic paralysis; Malignant hyperthermia

Indexed keywords

SODIUM CHANNEL; SODIUM ION;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CLINICAL ARTICLE; FEMALE; GENE LOCUS; GENETIC LINKAGE; HUMAN; MALE; MALIGNANT HYPERTHERMIA; MUSCLE WEAKNESS; MYOPATHY; PARALYSIS; PEDIGREE ANALYSIS; PERIODIC PARALYSIS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SKELETAL MUSCLE;

ADULT; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 19; DINUCLEOTIDE REPEATS; DNA PRIMERS; FEMALE; GENES, DOMINANT; HUMANS; HYPERKALEMIA; LINKAGE (GENETICS); LOD SCORE; MALE; MALIGNANT HYPERTHERMIA; MUSCLE, SKELETAL; MUTATION; PARALYSES, FAMILIAL PERIODIC; PEDIGREE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SODIUM CHANNELS;

EID: 0032567985     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19980226)76:1<21::AID-AJMG3>3.0.CO;2-S     Document Type: Article

References (31)

1. Ball S, Johnson K (1993): The genetics of malignant hyperthermia. J Med Genet 30:89-93.
2. Bender K, Senff H, Wienker TF, Spiess-Kiefer C, Lehmann-Horn F (1990): A linkage study of malignant hyperthermia (MH). Clin Genet 37:221-225.
3. Cannon S, Strittmatter S (1993): Functional expression of sodium channel mutations identified in families with periodic paralysis. Neuron 10: 317-326.
4. Deufel T, Golla A, Ilcs D, Meindl A, Meitinger T, Schindelhauer D, DeVries A, Pongratz D, MacLennan DH, Johnson KJ, Lehmann-Horn F (1992): Evidence for genetic heterogeneity of malignant hyperthermia susceptibility. Am J Hum Genet 50:1151-1161.
5. Ebers GC, George AL, Barchi RL, Ting-Passador SS, Kallen RG, Lathrop GM, Beckmann JS, Hahn AF, Brown WF, Campbell RD, Hudson AJ (1991): Paramyotonia congenita and hyperkalemic periodic paralysis are linked to the adult muscle sodium channel. Ann Neurol 30:810-816.
6. Fagerlund T, Islander G, Ranklev E, Harbitz I, Hauge JG, Mokleby E, Berg K (1992): Genetic recombination between malignant hyperthermia and calcium release channel in skeletal muscle. Clin Genet 41:270-272.
7. Fontaine B, Khurana TS, Hoffman EP, Bruns GA, Haines JL, Trofatter JA, Hanson MP, Rich J, McFarlane H, Yasek DM, Romano D, Guesella JF, Brown RH (1990): Hyperkalemic periodic paralysis and the adult muscle sodium channel α-subunit gene. Science 250:1000-1002.
8. Gillard EF, Otsu K, Fujii J, Khanna VK, de Leon S, Derdemezi J, Britt BA, Duff CL, Worton RG, MacLennan DH (1991): A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics 11:751-755.
9. Gillian CM, Heffron JJ, Lehane M, Marks A, McCarthy TV (1991): Analysis of expression of the human ryanodine receptor gene in malignant hyperthermia skeletal muscle tissue. Biochem Soc Trans 19:46s.
10. 2+ channel (CACNL1A3) to chromosome 19q31-q32. Genomics 15:107-112.
11. Hoffman E, Lehmann-Horn F, Rudel R (1995): Overexcited or inactive: Ion channels in muscle disease. Cell 80:681-686.
12. Hogan K (1997): To fire the train: A second malignant-hyperthermia gene. Am J Hum Genet 60:1303-1308.
13. Iles DE, Lehmann-Horn F, Scherer SW, Tsui LC, Olde Weghuis D, Suijkerbuijk RF, Heytens L, Mikala G, Schwartz A, Ellis FR, Stewart AD, Deufel T, Wieringa B (1994): Localization of the gene encoding the α2/δ subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families. Hum Mol Genet 3:969-975.
14. Jurkat-Rott K, Lehmann-Horn F, Elbaz A, Heine R, Gregg RG, Hogan K, Powers PA, Lapie P, Vale-Santos JE, Weissenbach J, Fontaine B (1994): A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet 3:1415-1419.
15. Kaus S, Rookoff M (1994): Malignant hyperthermia. Pediatr Clin North Am 41:221-237.
16. Koch MC, Ricker K, Otto M, Grimm T, Hoffman EP, Rudel R, Bender K, Zoll B, Harper PS, Lehmann-Horn F (1991): Confirmation of linkage of hyperkalemic periodic paralysis to chromosome 17. J Med Genet 28: 583-586.
17. Levitt RC, Olckers A, Meyers S, Fletcher JE, Rosenberg H, Isaacs H, Meyers DA (1992): Evidence for localization of a malignant hyperthermia susceptibility locus (MHS2) to human chromosome 17q. Genomics 14: 562-566.
18. MacLennan D (1992): The genetic basis of malignant hyperthermia. TIPS 13:330-334.
19. MacLennan D, Phillips M (1992): Malignant hyperthermia. Science 256: 789-794.
20. McCarthy TV, Healy JM, Heffron JJ, Lehane M, Deufel T, Lehmann-Horn F, Farrall M, Johnson K (1990a): Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2. Nature 343:562-564.
21. McCarthy TV, Healy JM, Lehane M, Heffron JJ (1990b): Recent developments in the molecular genetics of malignant hyperthermia: Implications for future diagnosis at the DNA level. Acta Anaesthesiol Belg 41:107-112.
22. McClatchey AI, Lin CS, Wang J, Hoffman EP, Rojas C, Gusella JF (1992a): The genomic structure of the human skeletal muscle sodium channel gene. Hum Mol Genet 1:521-527.
23. McClatchey AI, Trofatter J, McKenna-Yasek D, Raskind W, Bird T, Pericak-Vance M, Gilchrist J, Arahata K, Radosavljevic D, Worthen HG, Van den Bergh P, Haines JL, Gusella JF, Brown RH (1992b): Dinucleotide repeat polymorphisms at the SCN4A locus suggest allelic heterogeneity of hyperkalemic periodic paralysis ad paramyotonia congenita. Am J Hum Genet 50:896-901.
24. Monnier N, Procaccio V, Stieglitz P, Lunardi J (1997): Malignant-hyperthermia susceptibility is associated with a mutation of the α-1 subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am J Hum Genet 60:1316-1325.
25. Olckers A, Meyers DA, Meyers S, Taylor EW, Fletcher JE, Rosenberg H, Isaacs H, Levitt RC (1992): Adult muscle sodium channel α-subunit is a gene candidate for malignant hyperthermia susceptibility. Genomics 14:829-831.
26. Ott J (1991): "Analysis of Human Genetic Linkage." Baltimore: The Johns Hopkins Press, pp 165-193.
27. Ptacek L, Johnson K, Griggs R (1993): Genetics and physiology of the myotonic muscle disorders. N Engl J Med 328:482-489.
28. Ptacek LJ, Tawil R, Griggs RC, Engel AG, Layzer RB, Kwiecinski H, McManis PG, Santiago L, Moore M, Fouad G, Bradley P, Leppert MF (1994): Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 77:863-868.
29. Quane KA, Keating KE, Manning BM, Healy JM, Monsieurs K, Heffron JJ, Lehane M, Heytens L, Krivosic-Horber R, Adnet P, Ellis FR, Monnier N, Lunardi J, McCarthy TV (1994): Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: Implication for diagnosis and heterogeneity studies. Hum Mol Genet 3: 471-476.
30. + channel α-subunit in hyperkalemic periodic paralysis. Nature 354:387-389.
31. Sudbrak P, Procaccio V, Klausnitzer M, Curran JL, Monsieurs K, van Broeckhoven C, Ellis R, Heyetens L, Hartung EJ, Kozak-Ribbens G, Heilinger D, Weissenbach J, Lehman-Forn F, Mueller CR, Deufel T, Stewart AD, Lunardi J (1995): Mapping of a further malignant hyperthermia susceptibility locus to chromosome 3q13.1. Am J Hum Genet 56:684-691.